To construct a nomogram based on preoperative variables to better predict the likelihood of complications occurring within 30 days of radical nephroureterectomy (RNU).
Introduction
Upper tract urothelial carcinoma (UTUC) accounts for 5% of all urothelial malignancies and has an annual incidence in Western countries of~1-2 per 100 000 [1, 2] . Surgical excision via radical nephroureterectomy (RNU) with an ipsilateral bladder cuff is considered the referent standard for managing high grade, muscle-invasive or bulky UTUC [3] . Contemporary oncological outcomes after RNU have shown durable responses for localized disease [4] .
Many patients with UTUC are elderly and have multiple comorbidities, largely owing to associated risk factors for developing this malignancy. For example, in a recent cohort of~100 patients undergoing RNU, Lin et al. [5] highlighted a relatively high percentage of competing medical issues including hypertension (61%), hyperlipidemia (36%), diabetes (21%), as well as baseline cardiac (33%) and pulmonary (21%) disease. As such, peri-operative complications may be significant in this cohort of patients.
Objectifying the risk associated with RNU is essential for preoperative patient counselling with regard to recovery and convalescence, delivery of adjuvant therapies and even selection of RNU (vs endoscopic management). To date, however, there are limited data evaluating complications after RNU. A comprehensive review of RNU outcomes published by Rassweiler et al. [6] in 2004 noted major and minor complications rates of 0-29% and 0-45%, respectively. Subsequent studies have been conflicting, with singleinstitution series noting significantly higher rates of complications than those reported from population-based administrative datasets. Thus, while these studies provide some insight into peri-operative complications, translating these observations into improved patient care for individual patients is challenging.
The aims of the present study were twofold. Firstly, to better define complications after RNU, we rigorously reviewed 30-day events occurring after surgery using a standardized validated classification system. In doing so, we defined the incidence and severity of complications and identified risk factors associated with these peri-operative events. Secondly, we used this information to construct a nomogram based on preoperative variables to predict the likelihood of peri-operative complications within 30 days of RNU. Our belief was that such information would permit more personalized counselling for patients before RNU surgery.
Patients and Methods

Patient Selection
The medical records of 731 patients with clinically localized, non-metastatic UTUC undergoing RNU at eight academic medical centres between 2002 and 2014 were retrospectively reviewed. All patients had complete preoperative clinical, demographic and comorbidity score data. This study specifically focused on preoperative clinical variables to avoid the inherent confounding impact of final pathological features which would not be available until after RNU. RNU was performed using an open or minimally invasive technique with regional lymphadenectomy, at the discretion of the operating surgeon. All specimens were histologically confirmed to be urothelial carcinoma.
Grading of Complications
Peri-operative complications occurring within 30 days of surgery were graded using the modified Clavien-Dindo scale [7] ; minor complications were classified as Clavien grade ≤ II, while major complications were grade ≥ III. The number, severity, type and management of complications were also recorded.
Statistical Analysis
Continuous data are presented as median and range, and categorical data as number of patients (percentage of sample). The chi-squared or Fisher's exact test were used to evaluate the association between categorical variables, and the MannWhitney U-test was used to assess differences in continuous variables. Analyses were performed to develop a model using preoperative factors for predicting any postoperative complication. Associations were summarized using odds ratios (ORs) and 95% CIs from univariable and multivariable logistic regression models. A full multivariable model included all possible predictors, including age, race, gender, American Society of Anesthesiologists (ASA) score, ECOG performance status, Charlson comorbidity index (CCI) score, body mass index (BMI), individual comorbidities and receipt of neoadjuvant chemotherapy. To exclude variables with limited predictive ability from the full model, a stepwise backward variable selection with the likelihood ratio criterion was used, resulting in a reduced model.
A nomogram containing all variables of the reduced model was created using the R 'rms' software package, after incorporating restricted cubic splines to model the potential non-linear relationship for age. Discrimination was assessed using the area under receiver-operating characteristic curve (AUC-ROC). The apparent performance of the model measured by the AUC-ROC was estimated directly from the dataset that was used to develop the model and is therefore a biased optimistic estimate of discrimination. A nearly unbiased optimism-corrected estimate of AUC-ROC was derived using 200 bootstrap resamples as a method of internal validation (Fig. 1) . Calibration was assessed by comparing the predicted probabilities with the actual observed proportions. All statistical analyses were performed using the R 3.1.1 statistical package (http://cran.r-project.org).
Results
Clinical characteristics for the 731 patients included in this study, stratified by presence of any complications are shown in Table 1 . A total of 408 men and 323 women with a median (range) age of 70 (26-97) years and a BMI of 27 kg/m 2 were included. Of the total cohort, 75% were white, 50% had baseline chronic kidney disease (CKD) stage ≥ III and 25 patients (3%) received neoadjuvant chemotherapy before RNU. Hypertension (54%), hyperlipidemia (42%), and cardiac disease (22%) were the leading concurrent medical diagnoses in our patients. When considering comorbidity indices, ECOG performance status was ≥2 in 18% of the group. ASA score was ≥3 in 49% of patients, and 55% of the cohort had a CCI score of ≥4. A total of 534 (73%) cases were performed with the minimally invasive approach and 197 (27%) with the open technique.
Overall, 279 patients (38.2%) experienced a complication including 61 (22%) with events of Clavien grade ≥ III. Haematological, gastrointestinal and infectious aetiologies comprised >75% of complications. There were seven (1%) deaths noted in our cohort within 30 days of RNU. Increasing patient age (P < 0.001), white race (P = 0.001), ECOG performance status ≥2 (P < 0.001), increasing CCI score (P < 0.001), history of pulmonary disease (P = 0.015), hypertension (P = 0.019), diabetes (P = 0.022), hyperlipidemia (P = 0.003) and worsening CKD stage (P < 0.001) were all associated with post-RNU complications (Table 1) . Tables 2 and 3 show the associations of preoperative variables with minor (Clavien I and II) and major (Clavien ≥ III) complications, respectively. When specifically considering minor complications, increasing patient age (P < 0.001), white race (P < 0.001), male gender (P = 0.024), ECOG performance status ≥2 (P < 0.001), increasing CCI score (P = 0.001), history of pulmonary disease (P = 0.033), hypertension (P = 0.023), hyperlipidemia (P = 0.001) and worsening CKD stage (P < 0.001) were all associated with post-RNU events ( Table 2 ). Analysis of major complications was limited by the lower number of patients (n = 61). Nonetheless, in this group, only ECOG performance status ≥2 (P = 0.004) and increasing CKD stage (P = 0.021) were associated with post-RNU complications (Table 3) . Table 4 shows the univariable and multivariable logistic regression to predict the likelihood of complications after RNU. Given the relatively low number of major complications, this analysis considered all complications as the outcome variable of interest. The full multivariate model identified five variables associated with all complications, including patient age, race, ECOG performance status, CCI score and CKD stage. A reduced model, which incorporated variables in the full model with a P value of <0.1, identified similar variables with a similar AUC-ROC (72.2% reduced model vs 72.9% full model).
The reduced multivariate model was used to create a preoperative nomogram (Fig. 2) . Use of the nomogram is simple. For example, a 70-year-old (51 points) white (37 points) patient with an ECOG performance status of 1 (0 points), a CCI score of 1 (37 points) and CKD stage III (22 
Discussion
The 'gold standard' therapy for UTUC remains RNU with resection of an ipsilateral bladder cuff. Owing to baseline medical comorbidities inherent in this patient population, peri-operative complications are likely to be significant. Defining the likelihood of these complications is essential for adequate patient counselling [8, 9] . Furthermore, such complications may not only affect convalescence and recovery, but may also delay the administration of systemic adjuvant therapies in patients in the high-risk group [10] . This is particularly true when considering that many patients will have their pathological grade upstaged at RNU, with adverse pathological features portending inferior survival in the absence of additional therapy [11] [12] [13] .
In the present study of 731 patients undergoing RNU in one of eight academic medical centres, 279 patients (38%) experienced postoperative complications. Of the 299 total complications, 79% were minor (Clavien grades I and II) and 21% were major (Clavien grades III-V). Haematological, gastrointestinal and infectious causes accounted for >75% of observed events, and the 30-day mortality rate was just under 1%. Our data are fairly consistent with other carefully annotated single-institution series using standardized reporting schemes.
In 2012, Rajput et al. [14] reviewed their experience of patients undergoing laparoscopic RNU to specifically determine the impact of neoadjuvant chemotherapy on perioperative outcomes. In the present series of 82 patients, 40 (49%) experienced a postoperative complication, of which 85% (34 of 40) were of Clavien grades I and II and the remaining 15% (6 of 40) were of Clavien grades III and IV.
No peri-operative mortalities were identified and there were no differences observed in patients who received neoadjuvant chemotherapy. A similar single-institution series by Lin et al. [5] used the modified Clavien-Dindo classification to define the incidence and risk factors associated with peri-operative complications occurring within 30 days of RNU. In that cohort of 92 patients, 35 patients (38%) experienced complications within 30 days of RNU, including 11 (12%) with major complications. In their multivariate model, only ECOG performance status ≥2 (OR 3.9, 95% CI 1.6-7.4; P < 0.001) was independently associated with post-RNU complications.
Somewhat distinct, however, from the above studies are data originating from the BAUS registry [15] . In this registry series encompassing 863 RNU surgeries performed in 110 centres, the reported complication rates were significantly lower than described above. Specifically, the overall complication rate was 15%, of which Clavien grade ≥3 was reported in 4% and peri-operative death noted in nine patients (1%). Similarly low complication rates have been reported in several series originating from population datasets. In 2012, Hanna et al. [16] used the US Nationwide Inpatient Sample to identify patients with clinically localized UTUC managed by open RNU or laparoscopic RNU. They observed no differences in postoperative complications (15 vs 17%; P = 0.24) or in-hospital mortality (0.7 vs 1.3%; P = 0.12) between the two approaches. Also, in 2012, Ni et al. [17] published a systematic review and cumulative analysis of laparoscopic RNU vs open RNU for management of UTUC. In their analysis, complication rates were low, with no significant differences in intra-operative complications (4.4 vs 5.1%), minor postoperative complications (5.7 vs 7.8%), major postoperative complications (4.6 vs 3.8%), or peri-operative mortality (1.6 vs 0.7%) between surgical approaches. Whilst a previous study by the present authors did not focus on surgical approach (open vs minimally invasive surgery), given potential confounding bias, we found similarly that technique was not associated with postoperative complications [18] . Specifically, in this previous study that included the 732 patients from the present study, longer operation duration (OR 8.3, 95% CI 3.6-10.8; P = 0.004) and greater transfusion requirement (OR 6.8, 95% CI 2.4-8.7; P = 0.009) were the sole operative variables associated with postoperative complications after RNU.
Most recently, in 2015 a registry-based publication reported on the 30-day peri-operative outcomes of open vs minimally invasive RNU through investigation of the American College of Surgeons National Surgical Quality Improvement Program Database (ACS-NSQIP) [19] . In that study of 896 patients, 12.7% of patients experienced a complication within 30 days of RNU, with no difference between surgical approaches (open RNU 12.5% vs minimally invasive RNU 12.9%; P = 0.87). Ultimately, it is apparent that single or multicentre series that rigorously annotate complications appear to report higher rates, particularly of Clavien grades I and II complications. One has to wonder if the differences in reported rates (particularly lower in the registry trials) are a function of recall bias amongst other factors.
As a result of the biological aggressiveness of UTUC with the potential for subsequent disease recurrence, contemporary oncological outcomes after RNU remain poor, especially for patients with advanced UTUC. The UTUC collaboration reported results from 1 363 patients treated with RNU at 12 academic centres and found that 5-year recurrence-free and cancer-specific survival probabilities were 69 and 73%, respectively [4] . These observations highlight that current treatment paradigms may need to be augmented with multimodal therapy, including peri-operative chemotherapy [20] . However, as we have reported previously, a relatively low percentage of patients with adverse pathological features after RNU actually receive adjuvant chemotherapy [10] . The rationale behind the infrequent use of chemotherapy in these patients at high risk was unclear, but probably includes patient and physician preference, decreased renal function and the potential confounding impact of operative complications [21] .
Improving the quality of the healthcare delivery system has been a subject of importance worldwide. A huge emphasis has been placed on reducing postoperative complications and thus reducing costs and improving the delivery of care. The lack of a standardized reporting system for postoperative complications in the field of urology and many other urological specialties makes interpreting literature and measuring surgical outcomes difficult [8, 9] ; however, it is worth noting that the use of the grading complication system is slowly gaining impetus.
There are several noteworthy findings in the present study. Similarly to some of the previously published literature, the overall complication rate after RNU approached 40%. This study is also the first to associate age, race, ECOG performance status, CKD stage and CCI score as independent predictors of peri-operative complications. Lastly, similarly to other studies, we also found that BMI was not a factor in operation duration, estimated blood loss and complications rates [14, 22] . Given the rarity of UTUC, it is unlikely that a randomized trial examining peri-operative outcomes of RNU will be conducted.
Nomograms are currently considered the most accurate tool to predict outcomes after surgical treatment and may be especially beneficial for the management of this uncommon malignancy where evidence-based medicine is lacking [23] . By assigning points to the five preoperative variables, one can easily estimate the likelihood of a peri-operative complication. Predictive tools, such this this nomogram, can enable clinicians to accurately evaluate a patient's situation to counsel more objectively and to guide personalized clinical decisionmaking regarding management options. This information may encourage the use of endoscopic therapies and potentially defer RNU in certain patients in the high-risk group. Furthermore, we hope that this nomogram will also allow the use of a progressive postoperative pathway, which has proven beneficial in reducing the lengths of stay after surgical procedures of many types [24] . In this regard, we believe that creation of a nomogram yields incremental information beyond simply identifying risk factors for complications.
We acknowledge several limitations in this study. First, our study was a retrospective study of medical records. Thus, we suspect a degree of under-reporting and under-realization of minor complications which may not have been annotated in records. In addition, the multicentre nature of the study could contribute to variations in how complications are both graded and managed. Secondly, our nomogram was internally validated and further direction is geared to external validation through accrual of a large international multicentre cohort. Thirdly, the number of major complication events was fairly low, thereby rendering nomogram creation impossible for these specific events, which may affect decisions most significantly. Finally, these experiences are reflective of academic medical centre urological practices, which may be subject to referral bias. This occurrence may account for the higher complication rates observed in this study as well as other large tertiary referral centres compared with population registries. Despite these limitations, to the best of our knowledge, this study presents the most critical appraisal to date of complications that occur secondary to radical surgery for UTUC and the first to provide a nomogram for use in the preoperative setting.
In conclusion, using standard preoperative variables from this multi-institutional UTUC database, we found that the postoperative complication rate after RNU approaches 40%. Patient's age, race, ECOG performance status, CKD stage and CCI score were all independent predictive factors. These data were used to construct and validate a preoperative nomogram for predicting peri-operative complications after RNU. We hope such information will permit more accurate risk stratification on an individual case basis before radical surgery.
